Gastrointestinal Cancers课件.pptVIP

January 24-26, 2013 San Francisco, California;About These Slides;Faculty;Disclosures;Overview;Colorectal Cancer;Phase III TRIBE Trial: First-line Bev + FOLFIRI or FOLFOXIRI in mCRC;;TRIBE Trial of First-line Bev + FOLFIRI or FOLFOXIRI in mCRC: Response Rates;TRIBE Trial of First-line Bev + FOLFIRI or FOLFOXIRI in mCRC: Safety;Phase III AVEX Trial: First-line Capecitabine ± Bev in Elderly mCRC Pts;;AVEX Trial of First-line Capecitabine ± Bev in Elderly mCRC Pts: ORR and AEs;Tournigand C, et al. ASCO GI 2013. Abstract 457.;Tournigand C, et al. ASCO GI 2013. Abstract 457.;Phase III Trial: Pegfilg